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L Standards for relations of cardiothoracic surgical organizations with
industryRobert M. Sade, MD, for The American Association for Thoracic Surgery Ethics Committee and The
Society of Thoracic Surgeons Standards and Ethics CommitteeMost physicians are well aware of the interest the United
States Congress, various federal agencies, and state legisla-
tures have shown in the influence of companies that produce
drugs and devices on physicians’ use of these products.
Recently, the focus on industry’s influence in the health
care field expanded to include relations with professional
medical societies. In 2009, the Institute of Medicine pub-
lished a report, ‘‘Conflict of Interest in Medical Research,
Education, and Practice.’’1 Citing the growing interest in
Congress and elsewhere, the authors state, ‘‘Physicians
and researchers. and the institutions that carry out medical
research, education, clinical care, and practice guideline de-
velopment must recognize public concerns about conflicts
of interest and take effective measures soon to maintain
public trust’’ (p 16).1 Professional societies were named
among those institutions. Also in 2009, a group of influen-
tial physicians, medical sociologists, and bioethicists pub-
lished a paper in the Journal of the American Medical
Association that focused entirely on medical specialty soci-
eties and their relations with industry.2 The authors made
a series of recommendations, several of which were highly
controversial. In response to this increasing scrutiny, the
American Association for Thoracic Surgery (AATS) and
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Committee and STS Standards and Ethics Committee,
with developing a report and guidelines describing how car-
diothoracic societies interact with industry. As the Ethics
Forum began work on the project, it came to light that the
Council of Medical Specialty Societies (CMSS) was writ-
ing a document that addressed this issue. After a process
of vetting by the member societies, the ‘‘CMSS Code for In-
teractions With Companies’’3 was completed in the spring
of 2010 and the member societies were invited to approve
the document as presented. At that point, the CMSS Code
contained several provisions that were deemed worthy of
further consideration by STS, a member organization (the
AATS was not a member), and STS abstained in the ap-
proval vote. To carry out its charge from the AATS and
STS, the Ethics Forum used the CMSS Code as a model
and modified it to suit the needs of cardiothoracic surgery
specialty societies. By the end of January 2011, the final
version was completed, and the AATS and STS adopted
the ‘‘Cardiothoracic Surgical Organizations’ Standards for
Interactions With Companies.’’ As official policy of both
organizations, this document is being simultaneously
published by The Journal of Thoracic and Cardiovascular
Surgery and The Annals of Thoracic Surgery.ry c July 2011
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LCARDIOTHORACIC SURGICAL ORGANIZATIONS’ STANDARDS FOR INTERACTIONS WITH
COMPANIES*Cardiothoracic surgical organizations (‘‘Societies/Asso-
ciations’’) play an important role in reaching out to health
professionals, patients, and other groups. We guide biomed-
ical research, discover new therapies, and engage in high-
quality surgical practice. We offer educational opportunities
that help translate scientific and medical progress into the
efficient delivery of effective medical care, develop re-
sources that guide our members in advancing the standard
of care, and provide a forum for presenting new skills and
scientific developments.
For-profit entities that develop, produce, market or dis-
tribute drugs, devices, services or therapies used to diag-
nose, treat, monitor, manage, and alleviate cardiothoracic
diseases,y referred to in these Standards as ‘‘Companies,’’
also strive to help patients live longer and healthier lives.
The Companies invest resources to bring new drugs and de-
vices out of the laboratory and to the patient while maximiz-
ing value for shareholders. Physicians and patients count on*Adapted from CMSS Code for Interactions With Companies.A1
yAdapted from Advanced Medical Technology Association (AdvaMed). Code of
Ethics on Interactions With Health Care Professionals.A2
The Journal of Thoracic and CSocieties/Associations to be authoritative, independent voi-
ces in the world of science and medicine, and we believe
that public confidence in our objectivity is important to car-
rying out our mission. We believe that our interactions with
Companies must meet high ethical standards.A2
Societies/Associations’ interactions with Companies
may include receiving charitable donations, applying for
grants in support of programmatic activities, and conduct-
ing a range of business transactions.z In all of these interac-
tions, Societies/Associations are committed to acting with
integrity.
These Standards embody the core principles of our pro-
fession, and are intended to benefit both our members and
their patients, and to improve cardiothoracic surgical care.
Many of the relations and activities encouraged or re-
quired by these Standards are already in place, and those
that are not will be implemented within one year after
adoption.DefinitionsThe following terms are defined for purposes of these
Standards. The Society/Association recognizes that some
of the terms may be used or defined differently by others.
Some of these terms refer to types of interactions in which
the Society/Association may engage with nonprofit organi-
zations and individuals as well as with Companies.
Advertising
Advertising is a Business Transaction inwhich a Company
pays a fee to the Society/Association in exchange for the So-
ciety/Association’s publication of a promotional announce-
ment that highlights the Company or the Company’s
products or services. For purposes of these Standards, Adver-
tiser refers to a Company that purchases Advertising.
Business Transaction
A Business Transaction is an interaction between the So-
ciety/Association and a Company in which a Company pays
a fee to the Society/Association in exchange for the Society/
Association’s item, service, or product. Examples of Busi-
ness Transactions include Company payment of fees associ-
ated with subscriptions to Society/Association publications,
Advertising in Society/Association publications, registra-tions for Society/Association meetings, and exhibit space
rental.
Charitable Contribution
A Charitable Contribution is a gift, including an in-kind
gift, given by a Company to a qualified tax-exempt organiza-
tion (eg, the Society/Association or an affiliated organization)
for use in furthering the organization’s charitable purposes and
in accordance with applicable tax rules and legal standards.
Clinical Practice Guideline
A Clinical Practice Guideline is a systematically devel-
oped statement to assist practitioner and patient decisions
about appropriate health care for specific clinical circum-
stances. As used in these Standards, the term Clinical
Practice Guideline also refers to medical technology assess-
ments, clinical opinions, and other evidence-based clinical
practice tools, as well as updates to existing Clinical Prac-
tice Guidelines (‘‘Guideline Updates’’).
Company
ACompany is a for-profit entity that develops, produces,
markets, or distributes drugs, devices, services or therapies
used to diagnose, treat, monitor, manage, and alleviatezThese Standards do not address Societies/Associations’ interactions with nonprofit
entities or entities outside of the health care sector.
ardiovascular Surgery c Volume 142, Number 1 13
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Lhealth conditions.A3,A4 This definition is not intended to
include nonprofit entities, entities outside of the health
care sector, or entities through which physicians provide
clinical services directly to patients.
Continuing Medical Education (CME)
Continuing Medical Education (CME) consists of educa-
tional activities for which the attendee may receive CME
credit (American Medical Association [AMA] Physician’s
Recognition Award Credit, American Academy of Family
Physicians [AAFP] Prescribed or Elective Credit, American
Osteopathic Association [AOA] Credit—various cate-
gories) based on accreditation awarded to the provider by
a recognized accrediting body (eg, Accreditation Council
for Continuing Medical Education [ACCME], AOA,
AAFP). CME activities ‘‘serve to maintain, develop, or in-
crease the knowledge, skills, and professional performance
and relationships that a physician uses to provide services
for patients, the public, or the profession.A5,A6 For
purposes of these Standards, educational activities for
physicians that are not CME-accredited are considered
Non-CME Educational/Informational Programs.
Corporate Sponsorship
A Corporate Sponsorship is an arrangement in which
a Company, typically through its marketing department, pro-
vides monetary or in-kind support for a particular Society/
Association product, service, or event, and is then acknowl-
edged in connection with the product, service or event.
Corporate Sponsorships are distinct from Educational
Grants, and do not constitute Commercial Support of
CME. For purposes of these Standards, Corporate Sponsor
refers to a Company that provides a Corporate Sponsorship.
Educational Grant
AnEducationalGrant is a sumawardedby aCompany, typ-
ically through its grants office, for the specific purpose of sup-
porting an educational or scientific activity offered by the
Society/Association. Educational Grants awarded by a Com-
pany to support a CME activity are referred to in the ACCME
Standards forCommercialSupport as ‘‘Commercial Support’’
of CME.A7 An Educational Grant may also be ‘‘in-kind.’’14 The Journal of Thoracic and Cardiovascular SurgeKey Society/Association Leaders
The Key Society/Association Leaders include officers in
the Presidential line of succession (eg, the President-Elect,
the President, and the Immediate Past President) of the So-
ciety/Association’s membership organization, the chief ex-
ecutive officer of the Society/Association’s membership
organization, the Editor-in-Chief of the Society/Associa-
tion’s journal, and others the Society/Association may
designate.
Non-CME Informational/Educational Program
A Non-CME Informational/Educational Program is
a program offered by the Society/Association, Company
or other third party that provides educational or promotional
information and does not offer CME credit.
Research Grant
A Research Grant is an award that is given by the Soci-
ety/Association to an individual, institution or practice to
fund the conduct of scientific research. Companies may
provide the Society/Association with programmatic sup-
port (eg, an Educational Grant or Charitable Contribution)
designated for the specific purpose of funding Research
Grants.
Satellite CME Symposium
A Satellite CME Symposium is a Company-supported
CME program held as an adjunct to the Society/Association
meeting where CME credit for the Symposium is provided
by a third party CME provider, and for which the Society/
Association receives a fee.
Society/Association CME
Society/Association CME refers to CME programs that
are planned by the Society/Association and for which the
Society/Association, as an accredited CME provider, pro-
vides CME credit.
Society/Association Journal
The Society/Association journal is a peer-reviewed sci-
entific journal published by the Society/Association or by
a publisher on the Society/Association’s behalf.Standards for Interaction1. Independence From Company Influence
1.1. The Society/Association develops all educational ac-
tivities, scientific programs, products, services and advo-
cacy positions independent of Company influence, and
develops and adopts policies and procedures that foster in-
dependence.1.2. The Society/Association separates its efforts to seek
Educational Grants, Corporate Sponsorships, Charitable
Contributions, and support for Research Grants from its
programmatic decisions, assessing the availability of funds
only after independently determining that a program is
needed (eg, to address gaps in care or knowledge).ry c July 2011
xThe Pharmaceutical Research and Manufacturers of America (PhRMA) Code on In-
teractions With Health Care ProfessionalsA8 and the Advanced Medical Technol-
ogy Association (AdvaMed) Code of Ethics on Interactions With Health Care
ProfessionalsA3 do not permit Companies to give promotional, noneducational
‘‘reminder’’ items directly to health care professionals.
kSee Definition of Satellite CMESymposium. Based on the definition of Satellite CME
Symposium, Section 5.2 of these Standards does not apply to programs that are held
adjunct to Society/Association meetings but (1) are not Company-supported; (2) are
not CME accredited; or (3) for which the Society/Association does not receive a fee.
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L1.3. The Society/Association has identified the high-level
group responsible for guiding Society/Association interac-
tions with Companies.
1.4. The Society/Association useswritten agreementswith
Companies for Educational Grants, Corporate Sponsorships,
CharitableContributions, Business Transactions, and support
of Research Grants. These agreements specify the purpose of
the funds, the amount given, the term of the agreement, and
the separate roles of the Company and the Society/Associa-
tion. Such agreements show that a transaction is ‘‘arms
length,’’ establish clear parameters for the use of funds, and
affirm the independence of the Society/Association.
2. Transparency
2.1. The Society/Association’s conflict of interest poli-
cies and forms are available to its members and the public.
2.2. The Society/Association discloses Company support,
includingEducationalGrants,Corporate Sponsorships,Char-
itable Contributions, and support of ResearchGrants, making
this information available to its members and the public.
2.3. The Society/Association has written disclosure poli-
cies for Key Society/Association Leaders, Board members,
committee members and others who serve on its behalf, and
uses the disclosed information to manage conflicts of inter-
est in decision making. The Society/Association requires
volunteers to update disclosure information at least annu-
ally and when material changes occur.
2.4. The Society/Association discloses all financial and
uncompensated relationships that Key Society/Association
Leaders and members of the Board of Directors of the So-
ciety/Association’s membership organization have with
Companies, making this information available to its mem-
bers and the public.
3. Accepting Charitable Contributions
3.1. The Society/Association controls the use of Charita-
ble Contributions in a manner that is aligned with the Soci-
ety/Association’s strategic plan and mission.
3.2. The Society/Association accepts reasonable require-
ments for reporting on the uses of the donated funds and rea-
sonable restrictions on the purposes for which Charitable
Contributions will be used, but declines Charitable Contri-
butions if donor restrictions would influence Society/
Association programs or advocacy positions in a manner
that is inconsistent with the Society/Association’s mission.
3.3. The Society/Association has policies for consistent
and appropriate recognition of donors.
4. Accepting Corporate Sponsorships
4.1. The Society/Association declines Corporate Sponsor-
ship of an item or program if the item or program is inconsis-
tentwith theSociety/Association’s strategic planandmission.
4.2. The Society/Association does not place the names or
logos of Companies or products on Society/Association-The Journal of Thoracic and Cdistributed ‘‘reminder’’ items (eg, tote bags, lanyards, high-
lighters, notebooks, and luggage tags).x
4.3. Corporate Sponsors of Society/Association data reg-
istries are not allowed to participate in the management of
such registries in any way.
5. Society/Association Meetings
5.1. Educational Grants and Society/Association CME
5.1.1. The Society/Association complies with all AC-
CME Standards for Commercial Support, including by
adopting policies and procedures designed to identify and
manage conflicts of interest in Company-supported Soci-
ety/Association CME programs.
5.1.2. The Society/Association retains control over the
use of Educational Grants and implements safeguards de-
signed to ensure that educational programs are nonpromo-
tional and free from commercial influence and bias.
5.1.3. The Society/Association appoints its own planning
committees to select the objectives, content, faculty, and
format of educational activities in a manner that is consis-
tent with the Society/Association mission.
5.1.4. The Society/Association does not solicit supporters’
suggestions about program topics, speakers, or content.
5.1.5. The Society/Association prohibits presenters from
using slides with Company logos.
5.1.6. The Society/Association requires presenters in So-
ciety CME programs to give a balanced view of therapeutic
options, and encourages presenters to use generic names in
place of product trade names.
5.1.7. The Society/Association does not seek support for
product-specific topics.
5.1.8. The Society/Association makes reasonable efforts
to achieve a balanced portfolio of support for each Society/
Association CME program.
5.2. CME-Accredited Satellite Symposia
5.2.1. The Society/Association requires Satellite CME
Symposia to undergo an application process.k
5.2.2. The Society/Association requires Satellite CME
Symposia to comply with ACCME Standards.
5.2.3. The Society/Association distinguishes Satellite
CME Symposia from Society/Association CME in meeting
programs and promotional materials and requires third
party organizers of Satellite CME Symposia to do the
same.ardiovascular Surgery c Volume 142, Number 1 15
{The Society/Association does not accept Corporate Sponsorship, Educational Grants,
Charitable Contributions, support of Research Grants, or any other direct Company
support of Guideline development activities. Company support of the overall
mission-based activities of The Society/Association is not considered direct support
of Guideline development.
#For example, The Society/Association may decide not to permit panel members with
conflicts of interest to draft text or vote on panel recommendations.
**If Guideline development panel members and chairs (see Section 7.8) have con-
flicts of interest at the time of adoption of these Standards, the Society/Association
may permit these individuals to remain actively involved in drafting the Guideline.
However, each panel for which this exception is made must meet the requirements
of Section 7.7 by the time of the next Guideline Update. For the minority of panel
members who are not free of conflicts, The Society/Association will apply proce-
dures for disclosure and conflict of interest management developed in accordance
with Sections 7.5 and 7.6.
yyIn addition to minimizing potential conflicts, remaining free of conflicts of interest
helps to ensure that a panel chair remains eligible to participate in subsequent
Guideline Updates.
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L5.2.4. The Society/Association does not permit Key Soci-
ety Leaders to participate in Satellite CME Symposia as fac-
ulty members, presenters, chairs, consultants, or in any
other role besides that of an attendee who receives no hon-
oraria or reimbursement.
5.3. Non-CME Informational/Educational Programs
5.3.1. The Society/Association requires Non-CME Infor-
mational/Educational Programs to be clearly distinguished
from Society/Association CME.
5.3.2. Key Society/Association Leaders may not partici-
pate as leaders or presenters in Company promotional/mar-
keting events.
5.4. Exhibits
5.4.1. The Society/Association has written policies that
govern the nature of exhibits and the conduct of exhibitors,
including requiring exhibitors to comply with applicable
laws, regulations, and guidance.
6. Awarding of Research Grants
6.1. The Society/Association does not permit Companies
to select (or influence the selection of) recipients of Re-
search Grants.
6.2. The Society/Association appoints its own commit-
tees to select recipients of Research Grants based on peer
review of grant applications.
6.3. The Society/Association does not require recipi-
ents of Research Grants to meet with Company
supporters.
6.4. The Society/Association does not permit Companies
that support Research Grants to receive intellectual prop-
erty rights or royalties arising out of the grant-funded
research.
6.5. The Society/Association does not permit Companies
that support Research Grants to control or influence manu-
scripts that arise from the grant-funded research.
6.6. The Society/Association discloses Company pro-
grammatic support (eg, an Educational Grant or Charitable
Contribution) for the Society’s own research. The Society/
Association acts independently in selecting research topics
and conducting the research itself.
7. Clinical Practice Guidelines
7.1. The Society/Association bases Clinical Practice
Guidelines on scientific evidence.
7.2. The Society/Association follows a transparent
Clinical Practice Guideline development process that is
not subject to Company influence. For Clinical Practice
Guidelines and Guideline Updates developed after adop-
tion of these Standards, the Society/Association will pub-
lish a description of its Guideline development process,
including its process for identifying and managing con-
flicts of interest.16 The Journal of Thoracic and Cardiovascular Surge7.3.The Society/Association does not permit direct Com-
pany support of the development of Clinical Practice Guide-
lines or Guideline Updates.{
7.4.The Society/Association does not permit direct Com-
pany support for the initial printing, publication, and distri-
bution of Clinical Practice Guidelines or Guideline
Updates. After initial development, printing, publication
and distribution is complete, the Society/Association may
accept Company support for the Society/Association’s fur-
ther distribution of the Guideline or Guideline Update,
translation of the Guideline or Guideline Update, or repur-
posing of the Guideline content.
7.5. The Society/Association requires all Guideline de-
velopment panel members to disclose relevant relationships
prior to panel deliberations, and to update their disclosures
throughout the Guideline development process.
7.6. The Society/Association has procedures for deter-
mining whether financial or other relationships between
Guideline development panel members and Companies
constitute conflicts of interest relevant to the subject matter
of the Guideline, as well as management strategies that min-
imize the risk of actual and perceived bias if panel members
do have conflicts.#
7.7. The Society/Association requires that a majority of
Guideline development panel members are free of con-
flicts of interest relevant to the subject matter of the
Guideline.**
7.8. The Society/Association requires the panel chair (or
at least one chair if there are co-chairs) to be free of conflicts
of interest with respect to topics covered within the Guide-
line, and to remain free of conflicts of interest for at least
one year after Guideline publication.yy
7.9. The Society/Association requires that Clinical Prac-
tice Guideline recommendations be subject to multiple
levels of review, including rigorous peer review by a range
of experts. The Society/Association does not select as a re-
viewer any individual employed by or engaged to represent
a Company.ry c July 2011
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L7.10. The Society/Association’s Clinical Practice Guide-
line recommendations are reviewed and approved before
submission for publication by at least one Society/Associa-
tion body beyond the Guideline development panel.
7.11. Guideline manuscripts are subject to independent
editorial review by a journal or other publication where
they are first published.
7.12. The Society/Association publishes Clinical Prac-
tice Guideline development panel members’ disclosure in-
formation adjacent to each Clinical Practice Guideline
and identifies voting abstentions.
7.13. The Society/Association requires all Clinical Prac-
tice Guideline contributors, including expert advisors or re-
viewers who are not officially part of a development panel,
to disclose financial or other substantive relationships that
may constitute conflicts of interest, and manages such con-
flicts of interest.
7.14. Clinical Practice Guideline development panel
members must decline offers from positively or negatively
affected Companies to speak about the Guideline on behalf
of the Company for one year after publication.
7.15. Clinical Practice Guideline development panel
members and staff must not discuss a Guideline’s develop-
ment with Company employees or representatives, must not
accept unpublished data from Companies, and must not per-
mit Companies to review Clinical Practice Guidelines in
draft form.
8. The Society/Association’s Journal
8.1. The Society/Association’s journal maintains edito-
rial independence from the Society/Association and from
Advertisers.zz
8.2. The journal requires all authors to disclose all finan-
cial and other relationships with Companies in any way re-
lated to the content of the article. This disclosure should
appear on the first page of the article.
8.3. The journal requires editors and reviewers to disclose
financial and other relationships with Companies, and these
are made available to the public.
8.4. The journal’s Editor-in-Chief has the ultimate
responsibility for determining when a conflict of interest
should disqualify an editor or reviewer from reviewing
a manuscript, according to established policies.xx
8.5. The journal‘s policy prohibits submission of
‘‘ghost-written’’ manuscripts prepared by or on behalf of
Companies.zzEditorial independence should be consistent with accepted standards for medical
publishing, such as those established by the International Committee of Medical
Journal Editors (ICMJE)A9 and the World Association of Medical Editors
(WAME).A10
xxWhen establishing these policies, Society Journals may find it helpful to consult ac-
cepted standards for medical publishing, such as those established by ICMJEA11
and WAME.A12
The Journal of Thoracic and C9. Standards for Advertising
9.1. The journal has written policies governing advertis-
ing in the journal.
10. Standards for Licensing
10.1. The Society/Association does not permit the misuse
or unauthorized modification of its licensed materials, and
prohibits use of Society/Association trademarks to imply
Society/Association endorsement of Company products or
services.
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